• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊曲康唑在生物相关介质中溶解行为的体外评价。

In vitro evaluation of the dissolution behaviour of itraconazole in bio-relevant media.

作者信息

Ghazal Heba S, Dyas A Mark, Ford James L, Hutcheon Gillian A

机构信息

School of Pharmacy and Chemistry, Liverpool John Moores University, Liverpool, UK.

出版信息

Int J Pharm. 2009 Jan 21;366(1-2):117-23. doi: 10.1016/j.ijpharm.2008.09.003. Epub 2008 Sep 11.

DOI:10.1016/j.ijpharm.2008.09.003
PMID:18832020
Abstract

Drugs in the gastrointestinal tract are exposed to a medium of partially digested food, comprising mixtures of fat, protein and carbohydrate. The dissolution behaviour of itraconazole was evaluated in bio-relevant media which were developed to take this into account. Media containing milk with different fat contents, protein (albumin, casein, gluten and gelatin), carbohydrates (glucose, lactose and starch) and amino acids (lysine, glycine, alanine and aspartic acid) to mimic a digested meal and bile components (sodium taurocholate and lecithin) to represent a key endogenous digestive material were investigated. The effect of medium composition on the intrinsic dissolution rate of itraconazole was evaluated as this drug has extremely poor solubility and its bioavailability is affected by food. Dissolution tests were carried out in simple compendial media based on dilute solutions of hydrochloric acid or neutral solutions of phosphate buffer and in more complex media containing the dietary components. The data obtained showed that most of the dietary components enhanced the solubility compared to simulated gastric fluid (SGF) but to differing extents. The greatest increase in dissolution was observed with the addition of milk and albumin although an increase was also seen with other proteins, amino acids and simulated gastrointestinal fluids.

摘要

胃肠道中的药物会接触到一种由部分消化的食物组成的介质,该介质包含脂肪、蛋白质和碳水化合物的混合物。考虑到这一点,在生物相关介质中评估了伊曲康唑的溶解行为。研究了含有不同脂肪含量的牛奶、蛋白质(白蛋白、酪蛋白、麸质和明胶)、碳水化合物(葡萄糖、乳糖和淀粉)和氨基酸(赖氨酸、甘氨酸、丙氨酸和天冬氨酸)以模拟消化后的膳食的介质,以及含有胆汁成分(牛磺胆酸钠和卵磷脂)以代表关键内源性消化物质的介质。由于该药物的溶解度极差且其生物利用度受食物影响,因此评估了介质组成对伊曲康唑固有溶解速率的影响。在基于盐酸稀溶液的简单药典介质或磷酸盐缓冲液的中性溶液以及含有膳食成分的更复杂介质中进行了溶解试验。获得的数据表明,与模拟胃液(SGF)相比,大多数膳食成分提高了溶解度,但程度不同。添加牛奶和白蛋白后观察到溶解增加最大,尽管其他蛋白质、氨基酸和模拟胃肠液也有增加。

相似文献

1
In vitro evaluation of the dissolution behaviour of itraconazole in bio-relevant media.伊曲康唑在生物相关介质中溶解行为的体外评价。
Int J Pharm. 2009 Jan 21;366(1-2):117-23. doi: 10.1016/j.ijpharm.2008.09.003. Epub 2008 Sep 11.
2
The impact of food components on the intrinsic dissolution rate of ketoconazole.食物成分对酮康唑固有溶出速率的影响。
Drug Dev Ind Pharm. 2015;41(10):1647-54. doi: 10.3109/03639045.2014.983114. Epub 2014 Nov 19.
3
Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling.基于生物相关溶解试验结合生理基于药代动力学模型预测塞来昔布的食物对吸收的影响。
Eur J Pharm Biopharm. 2009 Sep;73(1):107-14. doi: 10.1016/j.ejpb.2009.05.009. Epub 2009 May 22.
4
Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol Dispersing.采用 KinetiSol Dispersing 生产用于提高伊曲康唑生物利用度的先进固体分散体。
Drug Dev Ind Pharm. 2010 Sep;36(9):1064-78. doi: 10.3109/03639041003652973.
5
Flocculated amorphous itraconazole nanoparticles for enhanced in vitro supersaturation and in vivo bioavailability.絮凝无定形伊曲康唑纳米粒以提高体外超饱和度和体内生物利用度。
Drug Dev Ind Pharm. 2012 May;38(5):557-70. doi: 10.3109/03639045.2011.616513. Epub 2011 Oct 1.
6
Enhancement of dissolution amount and in vivo bioavailability of itraconazole by complexation with beta-cyclodextrin using supercritical carbon dioxide.通过超临界二氧化碳与β-环糊精络合提高伊曲康唑的溶出量和体内生物利用度。
J Pharm Biomed Anal. 2007 Oct 18;45(2):243-50. doi: 10.1016/j.jpba.2007.06.011. Epub 2007 Jun 14.
7
In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media.使用具有生物相关性的溶出介质,采用流通溶出法对难溶性药物达那唑进行体内外相关性研究。
Eur J Pharm Sci. 2005 Mar;24(4):305-13. doi: 10.1016/j.ejps.2004.11.007. Epub 2005 Jan 6.
8
Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement.二盐酸伊曲康唑的制备及其增溶和溶出速率的评价
Int J Pharm. 2009 Feb 9;367(1-2):109-14. doi: 10.1016/j.ijpharm.2008.09.034. Epub 2008 Sep 30.
9
Estimation of intragastric drug solubility in the fed state: comparison of various media with data in aspirates.进食状态下胃内药物溶解度的估算:各种介质与抽吸物数据的比较。
Biopharm Drug Dispos. 2009 Sep;30(6):318-25. doi: 10.1002/bdd.670.
10
High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers.具有生物相容性稳定剂的雾化伊曲康唑纳米颗粒分散体具有高生物利用度。
Int J Pharm. 2008 Sep 1;361(1-2):177-88. doi: 10.1016/j.ijpharm.2008.05.003. Epub 2008 May 14.

引用本文的文献

1
Host-Guest Complexation of Itraconazole with Cyclodextrins for Bioavailability Enhancement.伊曲康唑与环糊精的主客体络合作用以提高生物利用度
Pharmaceutics. 2024 Apr 19;16(4):560. doi: 10.3390/pharmaceutics16040560.
2
Preparation and Characterization of Spray-Dried Hybrid Nanocrystal-Amorphous Solid Dispersions (HyNASDs) for Supersaturation Enhancement of a Slowly Crystallizing Drug.用于增强缓慢结晶药物过饱和度的喷雾干燥混合纳米晶体-无定形固体分散体(HyNASDs)的制备与表征
Nanomaterials (Basel). 2023 Aug 25;13(17):2419. doi: 10.3390/nano13172419.
3
Pediatric tinea capitis in Jilin Province: analyzing previous results from a new perspective.
吉林省小儿头癣:从新视角分析以往结果。
Mycopathologia. 2023 Oct;188(5):515-522. doi: 10.1007/s11046-023-00718-0. Epub 2023 Apr 6.
4
Itraconazole therapy for infant hemangioma: Two case reports.伊曲康唑治疗婴儿血管瘤:两例报告。
World J Clin Cases. 2021 Oct 6;9(28):8579-8586. doi: 10.12998/wjcc.v9.i28.8579.
5
Polymer⁻Surfactant System Based Amorphous Solid Dispersion: Precipitation Inhibition and Bioavailability Enhancement of Itraconazole.基于聚合物-表面活性剂体系的无定形固体分散体:伊曲康唑的沉淀抑制与生物利用度提高
Pharmaceutics. 2018 Apr 24;10(2):53. doi: 10.3390/pharmaceutics10020053.
6
Evolution of Choice of Solubility and Dissolution Media After Two Decades of Biopharmaceutical Classification System.二十年来生物药剂学分类系统后选择溶解度和溶出介质的演变。
AAPS J. 2017 Jul;19(4):989-1001. doi: 10.1208/s12248-017-0085-5. Epub 2017 May 17.
7
Lyophilized phytosomal nanocarriers as platforms for enhanced diosmin delivery: optimization and ex vivo permeation.冻干植物素纳米载体作为增强橙皮苷递送的平台:优化和体外渗透。
Int J Nanomedicine. 2013;8:2385-97. doi: 10.2147/IJN.S45231. Epub 2013 Jul 3.
8
Development and validation of a discriminative dissolution test for betamethasone sodium phosphate and betamethasone dipropionate intramuscular injectable suspension.研制并验证了一种鉴别性溶出试验方法,用于测定磷酸倍他米松钠和倍他米松二丙酸酯肌内注射混悬剂。
AAPS PharmSciTech. 2013 Mar;14(1):425-34. doi: 10.1208/s12249-012-9920-2. Epub 2013 Feb 1.